FY2025 · ended Dec 31, 2025 · Revenue $0, -100.0% YoY · Filed Mar 12, 2026
Synlogic, Inc. (SYBX) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $1.0 million. Free cash flow was -$4.4 million.
Revenue (TTM)
$0
Net income (TTM)
$-655,000
+37.2% vs year-ago TTM
Operating cash flow (TTM)
$-3.84M
-19.5% vs year-ago TTM
Free cash flow
$-4.36M
+86.2% vs prior year
EPS (TTM)
$-0.05
+37.7% vs year-ago TTM
Dividend per share
None
Shares outstanding
11.70M
+0.0% vs prior year
Net cash
$18.86M
FY 2024
Operating margin
-511875.0%
FY 2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SYBX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Winchester, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527599
- Former names
- Mirna Therapeutics, Inc. (until Aug 25, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $8,000 | $3.4M | $1.2M | $1.8M |
| Operating income | -$4.0M | -$41.0M | -$55.2M | -$67.4M | -$60.8M |
| Net income | -$1.0M | -$23.4M | -$61.3M | -$66.1M | -$60.6M |
| Diluted EPS | -$0.08 | -$1.92 | -$9.42 | -$13.83 | — |
| Operating cash flow | -$4.4M | -$31.7M | -$51.6M | -$56.9M | -$52.2M |
| Free cash flow | -$4.4M | -$31.7M | -$51.8M | -$57.6M | -$52.9M |
| Total assets | $15.4M | $19.8M | $75.5M | $110.9M | $174.7M |
| Stockholders' equity | $11.9M | $12.8M | $32.8M | $82.6M | $147.3M |
| Cash and investments | $14.7M | $18.9M | $47.7M | $77.6M | $136.6M |
| Total debt | — | $0 | $17.3M | $20.3M | $20.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Change in control, Regulation FD disclosure
|
Jul 29, 2026 | Jul 27, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K/A |
Amended current report
Listing notice, Other events
|
Jan 29, 2026 | Jan 16, 2026 |
All 626 Synlogic, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.